PT003 MDI Dose Confirmation Study

Trial Identifier: PT003004
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT01349816
Start Date: June 2011
Primary Completion Date: November 2011
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
USA, CA Rancho Mirage, CA, USA
USA, CO Colorado Springs, CO, USA
USA, CT Waterbury, CT, USA
USA, FL Clearwater, FL, USA
USA, FL Pensacola, FL, USA
USA, GA Stockbridge, GA, USA
USA, MN Minneapolis, MN, USA
USA, NC Charlotte, NC, USA
USA, NC Winston-Salem, NC, USA
USA, NE Omaha, NE, USA
USA, NY Brooklyn, NY, USA
USA, OH Cincinnati, OH, USA
USA, OR Medford, OR, USA
USA, SC Spartanburg, SC, USA